-The Morung Express Chizami: “The Nagas are very hard working people,” said Swarupama continually on her first visit to Nagaland from Yedakupalli village in Medak district of Telangana State. She is a senior Leader among the team of Dalit women farmers, videographers and coordinator here for the International Women’s Day and Biodiversity Festival observed by the North East Network in Chizami, Phek district, on March 8 and 9. The women are part...

-The New Indian Express BHUBANESWAR: Eminent agricultural economist Ashok Gulati on Monday emphasised on higher growth in agriculture sector for faster reduction of poverty. Addressing the second Odisha Knowledge Hub (OKH) lecture series on ‘Getting agriculture back on track in the growth agenda of the Nation and State’ at the Secretariat here, Gulati said the agriculture sector has the potential to grow at five per cent per annum as against the present...

-Press Release from Delhi Pension Parishad Activists from seven major campaigns stated unequivocally that the Union Budget for 2016-17 far from ‘Transforming India’, as claimed by the Finance Minister, Shri Arun Jaitley, is neglecting the interests of farmers, the poor and vulnerable both in nominal and real terms and subjecting every life-affirming program to severe  budget cuts. Activists from seven major campaigns such as the Right to Food Campaign , the...

-The Hindu The shutdown of the 220 MW Unit-1 of the Kakrapar Atomic Power Station located in Gujarat’s Surat district following leakage of heavy water used to cool the nuclear reactor, on March 11, the fifth anniversary of the Fukushima Daiichi nuclear plant disaster in Japan, is at once a reminder of the inherent risks associated with operating nuclear reactors and the importance of augmenting safety mechanisms. Unlike the Fukushima accident,...

-The Telegraph New Delhi: International humanitarian agency Medecins Sans Frontieres has filed an application to block US pharmaceutical company Pfizer from obtaining a patent in India for a vaccine against pneumonia and allow Indian vaccine manufacturers to make low-cost versions. The patent opposition moved by MSF has claimed that Pfizer's patent application, which describes methods of conjugating 13 serotypes (strains) of the bacterium Streptococcus pneumoniae into a single carrier vaccine, does not...